#Sustainability #China #Shanghai #Dow Jones #WuXi AppTec

WuXi AppTec’s Recognition on the 2026 Dow Jones Best-in-Class World Index

WuXi AppTec, an influential player in the global pharmaceutical CRDMO landscape, has made headlines by securing a spot on the 2026 Dow Jones Best-in-Class World Index. This prestigious index, which was formerly known as the Dow Jones Sustainability World Index, showcases companies fortified by strong sustainability practices across their operations. WuXi AppTec's selection is a testament to its commitment to responsible operational practices and long-term sustainable growth.

The Dow Jones Best-in-Class World Index is curated by S&P Global through its Corporate Sustainability Assessment (CSA). This assessment evaluates firms based on long-term economic, social, and environmental criteria, determining which companies rank among the elite in their respective industries. To qualify for inclusion, organizations must demonstrate outstanding performance, making WuXi AppTec's recognition a significant achievement.

Recognition of Sustainable Practices

Dr. Steve Yang, Co-CEO of WuXi AppTec, expressed pride in the company's inclusion in this esteemed index. He stated, _“We are honored to be included on the Dow Jones Best-in-Class World Index, which reflects WuXi AppTec's continued efforts to embed sustainability into our corporate strategy and daily operations.”_ His remarks underscore the company’s endeavor to act as a reliable partner in the pharmaceutical industry, fostering innovation while addressing pressing healthcare needs.

WuXi AppTec integrates sustainability deeply within its business model. The company aligns its operations to contribute positively to the pharmaceutical and life sciences sector, thereby enhancing its market position. The firm has earned accolades across various independent ESG frameworks, including:

• - MSCI ESG leadership rating for five years in succession, achieving an AAA rating in the latest assessment.
• - Inclusion in the S&P Global Sustainability Yearbook for four consecutive years.
• - Selection within the FTSE4Good Index Series for the past three years.
• - Recognition with a Gold medal in sustainability from EcoVadis for two consecutive years.
• - The highest A rating in CDP Water Security for two years and an A rating in CDP Climate Change for the first time.
• - Attainment of Prime Status in the ISS ESG Corporate Rating for two consecutive years.

These evaluations distinguish WuXi AppTec as a leader in the sustainability arena, directly reflecting its unwavering commitment to environmental, social, and governance principles.

Future Sustainability Goals

WuXi AppTec goes beyond recognition. The company has set future greenhouse gas emissions reduction targets validated by the Science Based Targets initiative (SBTi), committing to ambitious sustainability milestones reflective of both an ecological and social focus. Additionally, it supports the United Nations Global Compact (UNGC) and participates actively in the Pharmaceutical Supply Chain Initiative (PSCI). Such initiatives highlight WuXi AppTec's strategic partnership approach and commitment to advancing sustainability within the pharmaceutical supply chain.

With a global footprint in operations spanning across Asia, Europe, and North America, WuXi AppTec champions innovation, crucial in combating diseases and developing ground-breaking healthcare solutions. Through its unique CRDMO platform, WuXi collaborates with partners from over 30 countries, continually striving to achieve its vision that “every drug can be made, and every disease can be treated.” This vision not only drives the company's commitment towards research and development but also ensures an inclusive approach towards accessible healthcare solutions for patients worldwide.

WuXi AppTec’s recognition on the 2026 Dow Jones Best-in-Class World Index serves as a powerful affirming moment for both its stakeholders and the wider industry, reiterating the importance of commitment to sustainability in today's corporate landscape. This milestone is not just about recognition; it is a pledge to continue fostering a company culture centered on responsible practices and innovations that benefit healthcare as a whole.